Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Internal Medicine Physician in Tampa, FL
NPI: 1417217472Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Avan's Phone Numberphone_androidMobile
Get M.D. Avan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
2018 - 2026
FL State Medical License
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Medical Oncology
University Of Florida College Of Medicine
med.ufl.edu
Medical School
Until 2018
University of Florida
Residency • Internal Medicine
2012 - 2015
Fellowship • Hematology and Medical Oncology
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 83 | 159 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 67 | 76 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 53 | 53 |
| 4 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 53 | 59 |
Visual-spatial disembedding in Parkinson's disease.
Authors: Blaise Mooney, John Kiluk, Hatem Soliman, Robert Weinfurtner, Bethany Niell, Ricardo Costa, Nazanin Khakpour, Hyo Han, Susan Hoover, Brian Czerniecki, Marie Lee, Christine Laronga, Aixa Soyano Muller
Journal: NPJ Breast Cancer
Publication Date: 2025-03-17
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Capecitabine, DRUG: Cemiplimab
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: AstraZeneca
Intervention / Treatment: DRUG: Durvalumab, DRUG: Anastrozole 1mg, DRUG: Letrozole 2.5mg, DRUG: Exemestane 25 MG
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Florida Breast Cancer Foundation
Intervention / Treatment: DIAGNOSTIC_TEST: Magnetic Resonance Imaging